Unknown

Dataset Information

0

Mammalian target of rapamycin controls dendritic cell development downstream of Flt3 ligand signaling.


ABSTRACT: Dendritic cells (DCs) comprise distinct functional subsets including CD8? and CD8(+) classical DCs (cDCs) and interferon-secreting plasmacytoid DCs (pDCs). The cytokine Flt3 ligand (Flt3L) controls the development of DCs and is particularly important for the pDC and CD8(+) cDC and their CD103(+) tissue counterparts. We report that mammalian target of rapamycin (mTOR) inhibitor rapamycin impaired Flt3L-driven DC development in vitro, with the pDCs and CD8(+)-like cDCs most profoundly affected. Conversely, deletion of the phosphoinositide 3-kinase (PI3K)-mTOR negative regulator Pten facilitated Flt3L-driven DC development in culture. DC-specific Pten targeting in vivo caused the expansion of CD8(+) and CD103(+) cDC numbers, which was reversible by rapamycin. The increased CD8(+) cDC numbers caused by Pten deletion correlated with increased susceptibility to the intracellular pathogen Listeria. Thus, PI3K-mTOR signaling downstream of Flt3L controls DC development, and its restriction by Pten ensures optimal DC pool size and subset composition.

SUBMITTER: Sathaliyawala T 

PROVIDER: S-EPMC2966531 | BioStudies | 2010-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC3155298 | BioStudies
2019-01-01 | S-EPMC6642353 | BioStudies
2014-01-01 | S-EPMC3994898 | BioStudies
2016-01-01 | S-EPMC4744567 | BioStudies
2011-01-01 | S-EPMC3196467 | BioStudies
2018-01-01 | S-EPMC6063084 | BioStudies
2015-01-01 | S-EPMC4507574 | BioStudies
1000-01-01 | S-EPMC3122942 | BioStudies
2014-01-01 | S-EPMC4144735 | BioStudies
2010-01-01 | S-EPMC2856032 | BioStudies